ZAP trial: MRD-guided chemotherapy and maintenance de-escalation with zanubrutinib-g-CHOP in high-risk FL (Phase II)
Authors
- Lihua Qiu (ORCID: https://orcid.org/0000-0003-4637-1811)
- Shiyong Zhou
- L. Li (ORCID: https://orcid.org/0009-0009-4088-4430)
- Huilai Zhang (ORCID: https://orcid.org/0000-0002-0091-0026)
- Zhengzi Qian
- Wei Li (ORCID: https://orcid.org/0000-0001-6843-1980)
- Xianming Liu (ORCID: https://orcid.org/0000-0001-7752-1136)
- Zhao Peiqi
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)